🔗 Share this article

An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to message these accounts directly for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where groups with numerous of members share “before and after” images, injection guides and assertions of next-day British shipping. Vendors market the substance there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Experts Express Concerns

However, doctors and chemists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals administering products of uncertain source.

Some experts said the popularity for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for human use under the British medical regulations.

Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, risking penalties, legal action or imprisonment.

Service Response and Content Removal

According to TikTok, the platform has taken down problematic content and prohibited related hashtags and search suggestions. The company stated it was dedicated to keeping the service secure and allocating resources in strengthening compliance measures.

Online Trading Activities

Research also found communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of members, filled with photos of weight loss, positive reviews and detailed guides for mixing or administering at home.

After minutes of entering one group, a vendor shared WhatsApp details, where most purchases take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about body mass, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, messages display dark colored parcels with postal service labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how much time a injector should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram stated it regularly monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they cannot confirm. Even if the research behind this drug is sound, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose users to potentially significant medical dangers”.